Burundi vs Solomon Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Burundi
88.0%
in 2025
Solomon Islands
88.0%
in 2025
Burundi rank
79th
Solomon Islands rank
79th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Burundi
- Solomon Islands
How they compare
Burundi currently reports 88.0% against 88.0% in Solomon Islands, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Solomon Islands ahead.
Burundi ranks 79th and Solomon Islands ranks 79th of 192 countries.
Burundi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 76.3% | 38.8% | 37.5% | Burundi |
| 2020s | 90.3% | 87.5% | 2.8% | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Burundi or Solomon Islands?
- Burundi, at 88.0% against 88.0% in Solomon Islands as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Burundi and Solomon Islands?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Solomon Islands?
- 18 years are reported by both, from 2008 to 2025.
- How do Burundi and Solomon Islands rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Burundi ranks 79th and Solomon Islands ranks 79th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.